Results 24,641-24,660 of 34,956 for speaker:Seán Fleming
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Does that answer Deputy MacSharry's questions?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Could Ms Carr also get what is used in Sweden as well?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Ms Carr will send on to the committee the terms of reference and the criteria that were used. Could she have a medical person look at it in order to highlight the differences rather than have us wade through two sets of terms of reference?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Only five of the 63 who did not pass the Irish test went to Sweden.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Will Ms Carr get the information and send it to us?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Does Mr. Breen have a timescale by which the discovery process will be completed to allow him come to a conclusion?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Following that, somebody has to assess the discovery and come to a conclusion on how the agency will deal with the case. How long will it take, approximately, before Mr. Breen knows where he will go with the case?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: When Mr. Breen has completed discovery for the layperson, he will send that to the other side and will engage his own experts then to examine what he has discovered to advise him on whether there is a causal effect, etc.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: When does Mr. Breen believe we will be at the end of that process, after discovery and after his experts have given him firm advice on it?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: However, Mr. Breen is saying that he cannot do that today.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: I understand what Deputy MacSharry was saying, but Mr. Breen is saying we have a bit to go yet.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Mr. Breen might inform this committee, as a matter of courtesy, when he has completed the discovery and passed that milestone. Is he allowed do that?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: It is before the courts.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Right.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Mr. Breen mentioned earlier that if he had information about an independent review of a case he is dealing with, he would use the work that was obtained as part of an independent review and that perhaps would prevent him from having to second-guess or redo it. How many of those cases have happened? We have asked who did the independent reviews. I know the Minister for Health can request...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: By the Minister?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: And in the case of Portlaoise, the Minister had the report-----
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: They would be non-statutory. In the cases of Savita Halappanavar and Portlaoise, the Minister set up the inquiries under a specific section of legislation. They had a statutory basis. I am not diminishing it, but Mr. Breen is talking about an in-house thing. Would there be many of them?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: What is the ballpark figure? Is it ten or 100?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Would you know why the HSE would involve the agency? It sounds like a good thing that somebody would, but why would the HSE be going there?